Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials
- 1 December 2018
- journal article
- letter
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 79 (6) , 1141-1143
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- High-value subpopulation for skin pain improvement in adalimumab-treated patients with moderate to severe hidradenitis suppurativaJournal of the American Academy of Dermatology, 2017
- Hidradenitis SuppurativaMayo Clinic Proceedings, 2015
- Painful Hidradenitis SuppurativaThe Clinical Journal of Pain, 2010
- Hidradenitis suppurativaBritish Journal of Surgery, 2009